Abstract
Long-term safety of ustekinumab in patients with moderate to severe psoriasis through up to 5 years of continuous follow-up
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
